[go: up one dir, main page]

WO2009038012A1 - 複素環化合物 - Google Patents

複素環化合物 Download PDF

Info

Publication number
WO2009038012A1
WO2009038012A1 PCT/JP2008/066400 JP2008066400W WO2009038012A1 WO 2009038012 A1 WO2009038012 A1 WO 2009038012A1 JP 2008066400 W JP2008066400 W JP 2008066400W WO 2009038012 A1 WO2009038012 A1 WO 2009038012A1
Authority
WO
WIPO (PCT)
Prior art keywords
heterocyclic compound
pharmaceutically acceptable
acceptable salt
disease
hyperalgesia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/066400
Other languages
English (en)
French (fr)
Inventor
Toshio Nakamura
Shuji Saito
Mitsukane Yoshinaga
Hiroshi Ohta
Madoka Kawamura
Tomoko Ishizaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of WO2009038012A1 publication Critical patent/WO2009038012A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

式（１）で示される新規な複素環化合物若しくはその医薬上許容される塩、又はこれらを有効成分として含有する医薬は、ＮＰＦＦ２受容体への強力な作動作用を有し、疼痛、痛覚過敏症、摂食障害、肥満、糖尿病若しくは心血管疾患などの疾患の予防又は治療に有用である。 　　　　　　　
PCT/JP2008/066400 2007-09-18 2008-09-11 複素環化合物 Ceased WO2009038012A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007241502 2007-09-18
JP2007-241502 2007-09-18

Publications (1)

Publication Number Publication Date
WO2009038012A1 true WO2009038012A1 (ja) 2009-03-26

Family

ID=40467829

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/066400 Ceased WO2009038012A1 (ja) 2007-09-18 2008-09-11 複素環化合物

Country Status (1)

Country Link
WO (1) WO2009038012A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130002991A (ko) * 2010-02-08 2013-01-08 엠에스데 오쓰 베.베. 8-메틸-1-페닐-이미다졸［1,5-ａ］피라진 화합물
EP2567959A1 (en) 2011-09-12 2013-03-13 Sanofi 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2018152134A1 (en) * 2017-02-14 2018-08-23 Research Triangle Institute Proline-based neuropeptide ff receptor modulators

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62135473A (ja) * 1985-12-06 1987-06-18 Fujisawa Pharmaceut Co Ltd イミダゾ−ル縮合複素環化合物
WO2004058755A2 (en) * 2002-12-24 2004-07-15 Biofocus Plc Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
JP2007504220A (ja) * 2003-09-03 2007-03-01 ガラパゴス・エヌブイ イミダゾ［１，５−ａ］ピリジン又はイミダゾ［１，５−ａ］ピペリジン誘導体および５ＨＴ２Ａ受容体関連障害に対する薬剤の製造のためのその使用
JP2007509060A (ja) * 2003-10-15 2007-04-12 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド イミダゾピラジンチロシンキナーゼ阻害剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62135473A (ja) * 1985-12-06 1987-06-18 Fujisawa Pharmaceut Co Ltd イミダゾ−ル縮合複素環化合物
WO2004058755A2 (en) * 2002-12-24 2004-07-15 Biofocus Plc Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
JP2007504220A (ja) * 2003-09-03 2007-03-01 ガラパゴス・エヌブイ イミダゾ［１，５−ａ］ピリジン又はイミダゾ［１，５−ａ］ピペリジン誘導体および５ＨＴ２Ａ受容体関連障害に対する薬剤の製造のためのその使用
JP2007509060A (ja) * 2003-10-15 2007-04-12 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド イミダゾピラジンチロシンキナーゼ阻害剤

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130002991A (ko) * 2010-02-08 2013-01-08 엠에스데 오쓰 베.베. 8-메틸-1-페닐-이미다졸［1,5-ａ］피라진 화합물
KR101661383B1 (ko) 2010-02-08 2016-09-29 머크 샤프 앤 도메 비.브이. 8-메틸-1-페닐-이미다졸［1,5-ａ］피라진 화합물
EP2567959A1 (en) 2011-09-12 2013-03-13 Sanofi 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2018152134A1 (en) * 2017-02-14 2018-08-23 Research Triangle Institute Proline-based neuropeptide ff receptor modulators
CN110546136A (zh) * 2017-02-14 2019-12-06 研究三角协会 基于脯氨酸的神经肽ff受体调节剂
EP3583090A1 (en) 2017-02-14 2019-12-25 Research Triangle Institute, International Proline-based neuropeptide ff receptor modulators
EP3583090A4 (en) * 2017-02-14 2020-12-30 Research Triangle Institute, International PROLINE-BASED NEUROPEPTIDE FF RECEIVER MODULATORS
US11491136B2 (en) 2017-02-14 2022-11-08 Research Triangle Institute Proline-based neuropeptide FF receptor modulators
CN110546136B (zh) * 2017-02-14 2023-07-18 研究三角协会 基于脯氨酸的神经肽ff受体调节剂
US11826350B2 (en) 2017-02-14 2023-11-28 Research Triangle Institute Proline-based neuropeptide FF receptor modulators
US12390446B2 (en) 2017-02-14 2025-08-19 Research Triangle Institute Proline-based neuropeptide FF receptor modulators

Similar Documents

Publication Publication Date Title
WO2010122980A8 (ja) 新規甲状腺ホルモンβ受容体作動薬
WO2008136392A1 (ja) 経口投与用製剤
WO2009051119A1 (ja) ピリミジルインドリン化合物
MX2009011276A (es) Inhibidor de dpp-iv que incluye el grupo beta-amino, metodo para la preparacion del mismo y composicion farmaceutica que contiene el mismo para prevenir y tratar una diabetes o una obesidad.
WO2007060140A3 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
WO2010026436A3 (en) 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders
WO2009111700A3 (en) Oxadiazoanthracene compounds for the treatment of diabetes
WO2005044192A3 (en) Triazole compounds and uses related thereto
ZA200706021B (en) 1-thio-D-glucitol derivatives
WO2007135527A3 (en) Benzimidazolyl compounds
UA94455C2 (en) Oxadiazolidinedione compound
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
ZA200706354B (en) Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
WO2007106181A3 (en) Glucagon receptor antagonists, preparation and therapeutic uses
WO2006124447A3 (en) Substituted n-arylpyrrolidines as selective androgen receptor modulators
WO2009004082A3 (en) Anticonvulsive pharmaceutical compositions
WO2004052370A3 (en) Quinoline compounds for use in mch receptor related disorders
WO2008156094A1 (ja) ピリダジノン誘導体及びそれらを有効成分とするｐｄｅ阻害剤
WO2007065808A3 (en) Neuropeptide-2 receptor-agonists
WO2010052144A3 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
WO2006020959A3 (en) Substituted benzofused heterocycles
WO2011045232A3 (en) Neuropeptide-2 receptor (y-2r) agonists
WO2007105113A3 (en) Use of crf1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia
WO2007120270A3 (en) Glucagon receptor antagonists, preparation and therapeutic uses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08831339

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08831339

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP